Triterpenes as Potential Drug Candidates for Rheumatoid Arthritis Treatment.

betulinic acid celastrol ginsenosides inflammation rheumatoid arthritis saponins triterpenes

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
05 Jul 2023
Historique:
received: 25 05 2023
revised: 30 06 2023
accepted: 04 07 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease characterized by joint inflammation, swelling and pain. Although RA mainly affects the joints, the disease can also have systemic implications. The presence of autoantibodies, such as anti-cyclic citrullinated peptide antibodies and rheumatoid factors, is a hallmark of the disease. RA is a significant cause of disability worldwide associated with advancing age, genetic predisposition, infectious agents, obesity and smoking, among other risk factors. Currently, RA treatment depends on anti-inflammatory and disease-modifying anti-rheumatic drugs intended to reduce joint inflammation and chronic pain, preventing or slowing down joint damage and disease progression. However, these drugs are associated with severe side effects upon long-term use, including immunosuppression and development of opportunistic infections. Natural products, namely triterpenes with anti-inflammatory properties, have shown relevant anti-arthritic activity in several animal models of RA without undesirable side effects. Therefore, this review covers the recent studies (2017-2022) on triterpenes as safe and promising drug candidates for the treatment of RA. These bioactive compounds were able to produce a reduction in several RA activity indices and immunological markers. Celastrol, betulinic acid, nimbolide and some ginsenosides stand out as the most relevant drug candidates for RA treatment.

Identifiants

pubmed: 37511889
pii: life13071514
doi: 10.3390/life13071514
pmc: PMC10381804
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Int J Mol Sci. 2022 Dec 21;24(1):
pubmed: 36613560
Clin Exp Immunol. 2017 Jul;189(1):12-20
pubmed: 28369786
J Med Chem. 2012 Apr 12;55(7):3122-34
pubmed: 22435650
Phytother Res. 2022 Oct;36(10):3900-3910
pubmed: 36104304
Biomed Pharmacother. 2019 Jul;115:108909
pubmed: 31071508
Life Sci. 2021 Feb 1;266:118911
pubmed: 33333049
Best Pract Res Clin Rheumatol. 2014 Aug;28(4):539-49
pubmed: 25481548
Nat Prod Rep. 2022 Dec 1;:
pubmed: 36454108
Mol Biol Rep. 2023 May;50(5):4687-4706
pubmed: 37022525
Oxid Med Cell Longev. 2022 Apr 7;2022:6277760
pubmed: 35432723
Int J Mol Sci. 2021 Mar 06;22(5):
pubmed: 33800828
Pharm Biol. 2018 Dec;56(1):269-274
pubmed: 29651912
J Autoimmun. 2020 Jun;110:102400
pubmed: 31980337
J Nat Prod. 2016 Mar 25;79(3):629-61
pubmed: 26852623
Metabolites. 2022 Sep 05;12(9):
pubmed: 36144243
Biochim Biophys Acta. 2013 Jun;1830(6):3670-95
pubmed: 23428572
J Nat Prod. 2020 Mar 27;83(3):770-803
pubmed: 32162523
Phytochem Rev. 2022;21(6):1761-1842
pubmed: 35283698
J Cell Mol Med. 2023 Mar;27(5):593-608
pubmed: 36756687
Front Pharmacol. 2017 Sep 13;8:636
pubmed: 28955238
Inflammopharmacology. 2019 Aug;27(4):845-856
pubmed: 31165333
J Cell Biochem. 2019 Feb;120(2):2151-2158
pubmed: 30367550
Immunol Cell Biol. 2020 Mar;98(3):171-186
pubmed: 31856314
Int Immunopharmacol. 2020 Jul;84:106527
pubmed: 32402948
Int Immunopharmacol. 2022 Nov;112:109241
pubmed: 36116150
Front Immunol. 2021 Dec 15;12:790925
pubmed: 34975889
Int Immunopharmacol. 2022 Dec;113(Pt A):109376
pubmed: 36279670
Front Pharmacol. 2022 Jul 15;13:941270
pubmed: 35910383
J Ethnopharmacol. 2021 Apr 6;269:113707
pubmed: 33358855
Front Med (Lausanne). 2021 Oct 05;8:745601
pubmed: 34676228
Phytomedicine. 2021 Dec;93:153766
pubmed: 34624807
Genes (Basel). 2017 Sep 06;8(9):
pubmed: 28878153
Biomolecules. 2022 Jan 07;12(1):
pubmed: 35053246
Immunol Lett. 2020 Oct;226:1-6
pubmed: 32565114
Chin J Nat Med. 2018 May;16(5):330-338
pubmed: 29860993
Biomed Pharmacother. 2017 Sep;93:681-694
pubmed: 28692940
Front Immunol. 2022 Aug 01;13:945129
pubmed: 35979373
Mol Nutr Food Res. 2019 Feb;63(3):e1800543
pubmed: 30411492
Natl Sci Rev. 2022 Sep 29;9(11):nwac206
pubmed: 36404871
Sci Rep. 2016 Aug 02;6:30594
pubmed: 27481047
Clin Rev Allergy Immunol. 2021 Apr;60(2):175-199
pubmed: 32378144
Annu Rev Plant Biol. 2014;65:225-57
pubmed: 24498976
Immunol Med. 2023 Sep;46(3):143-152
pubmed: 36744577
Biomolecules. 2020 Jul 05;10(7):
pubmed: 32635659
Biochem Pharmacol. 2019 Jul;165:152-169
pubmed: 30910693
J Clin Med. 2022 Dec 02;11(23):
pubmed: 36498754
Phytomedicine. 2022 Oct;105:154378
pubmed: 35961265
J Pharmacol Sci. 2022 Jan;148(1):116-124
pubmed: 34924115
Lancet. 2016 Oct 22;388(10055):2023-2038
pubmed: 27156434
Front Pharmacol. 2022 Oct 07;13:983744
pubmed: 36278188
Ann Rheum Dis. 2010 Jan;69(1):169-74
pubmed: 19153104
Immunity. 2017 Feb 21;46(2):183-196
pubmed: 28228278
Eur J Pharmacol. 2015 Jul 15;759:278-86
pubmed: 25824900
Chem Biodivers. 2023 Feb;20(2):e202200853
pubmed: 36598091
J Agric Food Chem. 2022 Dec 28;70(51):16176-16187
pubmed: 36516328
Int Immunopharmacol. 2019 Sep;74:105725
pubmed: 31276975
Int Immunopharmacol. 2022 Oct;111:109038
pubmed: 35932612
Adv Clin Exp Med. 2021 Oct;30(10):1031-1041
pubmed: 34329545
Clin Exp Immunol. 2018 Nov;194(2):231-243
pubmed: 30277570
J Pharmacopuncture. 2019 Jun;22(2):55-67
pubmed: 31338244
Cell Mol Immunol. 2021 Jun;18(6):1584-1586
pubmed: 33637959
J Agric Food Chem. 2020 Apr 29;68(17):4893-4902
pubmed: 32275817
Nat Rev Rheumatol. 2021 Apr;17(4):224-237
pubmed: 33674813
Int Immunopharmacol. 2019 Oct;75:105563
pubmed: 31408840
Environ Toxicol. 2022 Jul;37(7):1814-1822
pubmed: 35446470
J Gene Med. 2020 Sep;22(9):e3204
pubmed: 32333475
Int Immunopharmacol. 2020 Dec;89(Pt A):107047
pubmed: 33039960
Clin Exp Rheumatol. 2022 Nov;40(11):2179-2187
pubmed: 36135939
Pharmaceuticals (Basel). 2023 Mar 02;16(3):
pubmed: 36986485
Int Immunopharmacol. 2021 Sep;98:107879
pubmed: 34147915
Int J Mol Med. 2021 Jul;48(1):
pubmed: 34013364
Phytomedicine. 2021 Jan;80:153398
pubmed: 33130474
J Biochem Mol Toxicol. 2019 Sep;33(9):e22373
pubmed: 31364231
Int Immunopharmacol. 2019 Feb;67:186-193
pubmed: 30553912
ACS Omega. 2021 Jan 14;6(3):2074-2084
pubmed: 33521447
Phytochem Rev. 2022;21(2):537-563
pubmed: 34812259
Nat Rev Rheumatol. 2015 Jul;11(7):390-400
pubmed: 25825281
Nat Protoc. 2007;2(5):1269-75
pubmed: 17546023
Front Med (Lausanne). 2022 Jul 22;9:909879
pubmed: 35935802
Phytochem Rev. 2015;14(4):675-690
pubmed: 26213526
Int J Mol Sci. 2018 Aug 24;19(9):
pubmed: 30149545
Int Immunopharmacol. 2022 Jun;107:108557
pubmed: 35247778
J Food Biochem. 2021 Apr;45(4):e13673
pubmed: 33624882
Phytomedicine. 2021 Dec;93:153801
pubmed: 34758437
Biochem Pharmacol. 2017 Feb 15;126:69-78
pubmed: 27965071
JAMA. 2018 Oct 02;320(13):1360-1372
pubmed: 30285183
Biomed Pharmacother. 2020 Oct;130:110568
pubmed: 32745911
BMC Complement Med Ther. 2021 May 25;21(1):149
pubmed: 34034706
Front Plant Sci. 2019 Dec 17;10:1523
pubmed: 31921225
J Cell Physiol. 2018 Nov;233(11):8740-8753
pubmed: 29761884
Phytother Res. 2022 Apr;36(4):1459-1506
pubmed: 35229374
Front Biosci (Landmark Ed). 2011 Jan 01;16(3):980-96
pubmed: 21196213
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3391-3398
pubmed: 31394949
Biomolecules. 2020 Jul 14;10(7):
pubmed: 32674342
Int Immunopharmacol. 2019 May;70:274-283
pubmed: 30851708
Autoimmun Rev. 2021 Feb;20(2):102735
pubmed: 33346115
Bone Res. 2018 Apr 27;6:15
pubmed: 29736302
Phytochemistry. 2004 Feb;65(3):261-91
pubmed: 14751299
Arthritis Rheum. 2013 Nov;65(11):2773-82
pubmed: 23897126
Semin Immunol. 2011 Apr;23(2):92-8
pubmed: 21376627
Planta Med. 2019 Aug;85(11-12):802-814
pubmed: 30658371
Bioorg Chem. 2020 May;98:103744
pubmed: 32179280
Front Immunol. 2022 May 25;13:887460
pubmed: 35693791
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
Int Immunopharmacol. 2017 Aug;49:118-125
pubmed: 28577436
Ann Rheum Dis. 2016 Jun;75(6):1255-61
pubmed: 26209657
Int J Mol Sci. 2018 Aug 05;19(8):
pubmed: 30081592
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Nat Rev Drug Discov. 2021 Mar;20(3):200-216
pubmed: 33510482
Immunity. 2022 Dec 13;55(12):2255-2270
pubmed: 36516818
Nucleic Acids Res. 2018 Jan 4;46(D1):D586-D594
pubmed: 29045755
Am J Transl Res. 2020 Dec 15;12(12):7709-7723
pubmed: 33437356
Semin Immunopathol. 2022 Jan;44(1):47-62
pubmed: 35088123

Auteurs

Célia Faustino (C)

iMed.ULisboa, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Avenida Prof. Gama Pinto, 1649-003 Lisbon, Portugal.

Lídia Pinheiro (L)

iMed.ULisboa, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Avenida Prof. Gama Pinto, 1649-003 Lisbon, Portugal.

Noélia Duarte (N)

iMed.ULisboa, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Avenida Prof. Gama Pinto, 1649-003 Lisbon, Portugal.

Classifications MeSH